A new prescription eye drop could make reading glasses a thing of the past, which would be a game-changer for 128 million Americans. It's hard to imagine a world without glasses, as almost a third of ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults with presbyopia. This age-related condition affects more than 100 million ...

In 2021, the very first drops to treat this condition were launched to much acclaim, but there's a reason VIZZ drops are considered first-in-class. Vuity (pilocarpine hydrochloride 1.25%) is a ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. The US Food and Drug Administration has approved the first eye drop ...

LENZ Therapeutics, Inc. ( NASDAQ: LENZ) Therapeutics, Inc. Citi's Biopharma Back to School Conference September 3, 2025 9:45 AM EDT ...

The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, maker Lenz Therapeutics announced on Thursday. It marks the first ...

Reading glasses might be the next thing to go the way of the flip phone. The FDA just approved VIZZ, a once-daily eye drop that helps you see up close without glasses. That’s a big deal if you’re over ...

The FDA has approved Lenz Therapeutics’ aceclidine (Vizz) for presbyopia, the loss of near vision associated with ageing. The cholinergic muscarinic receptor agonist was marketed for glaucoma in ...